Podcasts about medicine pulmonary

Mira M. John, MD, and Başak Çoruh, MD, join CHEST Podcast Moderator Gretchen Winter, MD, to discuss postinterview communication practices among fellowship applicants and program directors.

Welcome to this special medical review episode of Everyday Oral Surgery. Today, we are joined once again by the Oral and Maxillofacial Surgeon, Dr. Andrew Jenzer, DDS. Dr. Jenzer is here to walk us through all things related to pulmonary physiology and pathology, and the various methods of management and care. We begin with the basics of pulmonary problems that may arise in patients before moving on to a detailed discussion about the relationship between applied physiology, oxygen, and math. Then, we dive into the world of PFTs, explore common pulmonary disease states, and our guest details what every medical professional needs to know about pulmonary embolisms. Be sure to take notes for this one!Key Points From This Episode:For this special medicine review, we welcome Dr. Andrew Jenzer, DDS back to the show. The basics of pulmonary issues that may arise in patients. A detailed discussion on applied physiology, oxygen, and math. Recommendations for the amount of oxygen that should be delivered via nasal cannula.  Pulmonary function tests; the ins and outs of PFTs.  Exploring common pulmonary disease states, starting with asthma. Defining and treating bronchospasms and laryngospasms. Chronic obstructive pulmonary disease – what it is and how to handle it. What all medical professionals need to know about pulmonary embolisms. Links Mentioned in Today's Episode:Dr. Andrew Jenzer — https://surgery.duke.edu/profile/andrew-clark-jenzer Dr. Andrew Jenzer Email — andrew.jenzer@duke.edu KLS Martin — https://www.klsmartin.com/en/   KLS Martin 35% Discount Code — StuckiFavs Everyday Oral Surgery Website — https://www.everydayoralsurgery.com/ Everyday Oral Surgery on Instagram — https://www.instagram.com/everydayoralsurgery/ Everyday Oral Surgery on Facebook — https://www.facebook.com/EverydayOralSurgery/Dr. Grant Stucki Email — grantstucki@gmail.comDr. Grant Stucki Phone — 720-441-6059 

Clinical trials can provide patients with early access to cutting-edge medicines under close medical supervision, yet the majority still do not reflect the increased diversity and complexity of the U.S. and global populations. Join us for an engaging discussion on the latest efforts to disrupt the traditional approach to clinical research and build capacity in communities that are historically underserved to ensure greater equity in access to care. Moderator Christina Edwards, MHA Director, Clinical Trials Center for Clinical and Social Research, National Minority Quality Forum Christina Edwards began her academic career at Howard University, earning her Bachelor of Science. She later earned her Master of Health Administration from George Washington University Milken Institute School of Public Health. A research coordinator position at an NYC research clinic would offset her career into the clinical research field. Years later she ventured into academic research at Weill Cornell Medicine, managing a multisite, NIH funded, pediatric study for children with Crohn's disease. She later transitioned to the New York –Presbyterian Health System coordinating industry sponsored clinical trials for the Department of Medicine- Pulmonary and Critical Care, now serving as the Clinical Trial Director for Center for Clinical and Social Research at NMQF. Panelists Salvatore Alesci, MD, PhD SVP, Clinical & Social Research Institute National Minority Quality Forum Dr. Alesci is a physician-scientist and healthcare executive with over two decades of working experience spanning multiple leadership roles in the government research and biopharmaceutical sectors. His expertise in R&D strategy and translational medicine have been applied to multiple therapy areas and drug pipelines. Dr. Alesci is uniquely poised to lead NMQF's efforts in fostering innovative research to promote health equity. Dr. Alesci received his M.D. (cum laude) and a Ph.D. in Experimental Endocrine and Metabolic Sciences from University of Messina, School of Medicine (Italy). After his post-graduate training, Dr. Alesci spent almost a decade conducting cutting-edge basic and translational research on the interplay between the neuroendocrine and immune systems at the National Institutes of Health (NIH). Dr. Alesci left the NIH to join the biopharmaceutical industry in 2006, serving in a number of Translational Medicine leadership roles at Wyeth, Pfizer and Merck. and leading efforts to “de-risk” several drug candidates as they progressed through the pipeline. More recently, Dr. Alesci has served as Chief Scientist and Strategy Officer and Chair of the Scientific Advisory Council at Beyond Celiac. Lloryn Hubbard Director, Patient Diversity PPD Clinical Research, Thermo Fisher Scientific Lloryn Hubbard is an accomplished clinical operations professional and leader in ensuring diverse populations are represented in clinical research. As head of Patient Diversity at PPD, Lloryn has strategic oversight over the company's clinical trial health equity efforts and leads a team of specialists focused on optimizing drug development for patient diversity. Prior to PPD, she was a project lead for Health Equity and Population Science at Genentech where she led impactful efforts to address disparities in medicine, including spearheading the development of a portfolio of solutions to embed inclusive research across the drug development life cycle. Foster Rockwell Director, Enterprise Learning PPD Clinical Research, Thermo Fisher Scientific Foster Rockwell is a talent development professional with over 25 years of experience creating and directing adult learning programs that improve organizational performance. He is the program manager for PPD's SiteCoach training for research naïve sites and he provides oversight for PPD's SiteCoach Patient Diversity in Clinical Trials training program.

Pulmonary is 10% of the Emergency Medicine End of Rotation Exam and 10% of the PANCE. Review common respiratory emergencies including asthma, pneumonia, viral infections, and more!

Libby Znaimer is joined by David Cravit, Vice President of Zoomer Media and Chief Membership Officer at CARP, Peter Muggeridge, Senior Editor of Zoomer Magazine and Bill VanGorder, Chief Operating Officer and Chief Policy Officer of CARP. This is the first time Libby chats with the Zoomer Squad since Ontario LTC Minister made all of those promises to improve the long-neglected sector last week. One of those pledges included providing $270-million dollars in funding towards hiring 4,000 LTC staff by the end of the fiscal year. This commitment is part of the longer-term goal of providing nursing home residents with an average of 4 hours of care per day by the year 2025-a commitment that the province wants to enshrine in the Ontario Long-Term Care Act. And, last week, Minister Phillips announced that the province is mandating COVID-19 vaccination for all LTC staff with a deadline for Nov. 15. Also, Phillips didn't only talk to Libby last week, he also spoke to Bill over at CARP. What did they discuss? Tune in to hear the latest. --- SLEEP IS IMPORTANT: HERE

Today's Innovations in Medical Education (TIME): Understanding and Moving Beyond Bias and Microaggressions: The Impact on Academic Medicine March 16th, 2021 | 4:00-5:00pm Khalilah Latrece Gates, MD Assistant Dean of Medical Education Assistant Professor of Medicine (Pulmonary and Critical Care) and Medical Education Learning Objectives At the end of this presentation, participants should be able to: Define various forms of bias and microaggressions. Identify tools/skills available to reduce bias. Become familiar with the resources available to assist in bias reduction at Feinberg. Disclosure Statement Dr. Khalilah Gates has nothing to disclose. Course director Dr. Mary McBride has nothing to disclose. Feinberg School of Medicine CME leadership and staff have nothing to disclose: Clara J. Schroedl, MD, Medical Director of CME, Sheryl Corey, Director of CME, Allison McCollum, Senior Program Coordinator, Katie Daley, Senior Program Coordinator, and Rhea Alexis Banks, Administrative Assistant 2.

You asked and we answered! COVID Vaccine 101. Today we sit down today with Dr. Jamie Rutland, MD. Doctor, Triple board certified in Internal Medicine, Pulmonary & Critical Care, COVID frontline provider, National Spokesperson, and owner of his private practice, “West Coast Lung.” Dr. Rutland is an expert in Asthma, COPD, ILD, EBUS, Navigational Bronchoscopy, and yes, Vaping. As a National Spokesman for the American Lung Association, he is passionate about community education and speaks frequently about Pulmonary Diseases. We deep dive into not only the vaccine, but also the depths of COVID. We wanted to bring you the BEST, and this man is nothing short of EXCELLENT in providing you reliable science based education on this HOT TOPIC. He is also a husband, father, puppy rescue advocate, sports fanatic, sneaker head, & social media curator.  To connect with us: Nurse Tori click HERE   Sam Manassero click HERE Cellfie Show @cellfiepodcast   Cellfie Show  https://www.cellfiepodcast.com/ (https://www.cellfiepodcast.com) ZDoggMD “THEY MAKE PATIENTS DIE ALONE…AND WE LET THEM” https://zdoggmd.com/dying-alone/ (https://zdoggmd.com/dying-alone/) Cellfie Podcast Merch  https://www.cellfiepodcast.com/shop-1 (https://www.cellfiepodcast.com/shop-1) Connect with us: https://www.cellfiepodcast.com/cellfieshowcontact (https://www.cellfiepodcast.com/cellfieshowcontact) Music: https://www.purple-planet/ (https://www.purple-planet).

Kieran Walsh, clinical director at BMJ, asks Matt Castleden, GP and editor for BMJ Best Practice and BMJ Learning, to summarise the latest clinical guidance in acute medicine. Dr Castleden updates us on recent recommendations on pulmonary embolism, and also acute respiratory distress and vaping associated lung injury. For more information, take a look at the BMJ Best Practice topic on pulmonary embolism: bestpractice.bmj.com/topics/en-gb/3000115 The BMJ Best Practice topic on acute respiratory distress syndrome: bestpractice.bmj.com/topics/en-gb/374

MORE ABOUT DR. KHALILAH GATES: Khalilah Gates, MD, is a pulmonary and critical care specialist at Northwestern Memorial Hospital. Dr. Gates’ clinical interests include pulmonary infections, COPD, asthma, and sepsis. Her research interests relate to impairment of pulmonary host defense and immune mechanisms which contribute to pulmonary disease. She received her MD from Loyola University/Stritch School of Medicine where she also completed her residency in internal medicine. Dr. Gates then undertook a fellowship training in pulmonary and critical care medicine at Northwestern University, McGaw Medical Center where she now is the Assistant Dean of Medical Education and an Assistant Professor of Medicine (Pulmonary and Critical Care) and Medical Education.

Dr. Ben Singer, Assistant Professor of Medicine (Pulmonary and Critical Care) and Biochemistry and Molecular Genetics at Northwestern Medicine joins The Roe Conn Show to explain why COVID-19 affects people differently, and whether or not there are actually two strains of the virus being spread. “Better knowledge means better health for you and your family. […]

THIS EPISODE WAS MADE IN COLLABORATION WITH THE PEDIATRIC OVERFLOW PLANNING CONTINGENCY RESPONSE (POPCoRN) NETWORK https://www.popcornetwork.org/   Course: Crash Course in Adult Inpatient Medicine - Pulmonary Course Director: Tony R Tarchichi M.D.  - Associate Professor in Dept of Pediatrics at the University of Pittsburgh Course Director: John Kennedy M.D. - Associate Professor in Pulmonary & Critical Care Medicine at Brigham and Women's Hospital.  Course Director: Ahmet Z. Uluer D.O. - Associate Professor in Pulmonary & Critical Care Medicine at Brigham and Women's Hospital.  Disclosures: None This Podcast series was created for Pediatric Hospitalists or those healthcare professionals who take care of hospitalized children.  This episode is Crash Course in Adult Inpatient Medicine - Pulmonary. As always there is free CME credit of up to 1 AMA category 1 for listening to this podcast and going to the Univ of Pitt site. See the link below.  ______________________________________________________ Objectives: Upon completion of this activity, participants will be able to: Review Differences between Asthma in adults and Pediatrics. Review invasive and non-invasive airway procedures for adults with respiratory distress due to COVID-19. Review COPD in adults and acute exacerbation treatments. ______________________________________________________ Released:  4/13/2020, Reviewed 4/13/2020, Expire: 4/13/2021 If you are new to the Internet-based Studies in Education and Research (ISER) website (which is how you will get your CME credit), you will first need to create an account: Step 1. Create an Account https://www.hsconnect.pitt.edu/HSC/home/create-account.do If you have used the ISER website in the past, you can click on the link below and then log onto in order to complete the evaluation for this training: Step 2. To access the test for CME credit:   Accreditation Statement: The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The University of Pittsburgh School of Medicine designates this enduring material for a maximum of  (1)  AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

In this episode, Dr. Perez discusses the diagnostic evaluation of the patient with pulmonary hypertension at the clinic. Vinicio de Jesus Perez, MD is Assistant Professor of Medicine (Pulmonary and Critical Care Medicine) at the Stanford Adult PH Clinic where he trains fellows pursuing careers in PH and IPF.  Learn more about pulmonary hypertension trials at www.phaware.global/clinicaltrials. Never miss an episode with the phaware® podcast app. Follow us @phaware on Facebook, Twitter, Instagram, YouTube & Linkedin Engage for a cure: www.phaware.global/donate #phaware #phawareMD @PHatStanford 

In this episode, Dr. Perez discusses ongoing clinical studies in #pulmonaryhypertension and what that means for practitioners & patients with PH. Vinicio de Jesus Perez, MD is Assistant Professor of Medicine (Pulmonary and Critical Care Medicine) at the Stanford Adult PH Clinic where he trains fellows pursuing careers in PH and IPF.  Learn more about pulmonary hypertension trials at www.phaware.global/clinicaltrials. Never miss an episode with the phaware® podcast app. Follow us @phaware on Facebook, Twitter, Instagram, YouTube & Linkedin Engage for a cure: www.phaware.global/donate #phaware #phawareMD @PHatStanford 

Listen to the podcast for why each multiple choice answer is right or wrong!1. A 21 YO F who is taking OCPs presents to the ED with increasing SOB starting 4 hours ago. On PE she’s tachycardic and has tachypnea at 23 breaths a minute. Her BP is 120/80. She has wheezing to all lung fields and appears to be in moderate distress. Both calves are mildly edematous and somewhat tender. What will you do next?A. CT chest B. Chest x-ray C. Ventilation to perfusion scan D. Pulmonary arteriography E. MRI chest2. A 33 YO M presents for an evaluation of a chronic cough for the past 6 months. He does not smoke and does not report any seasonal allergies. He denies any systemic complaints such as fever or weight loss, and does not have any symptoms of heartburn or regurgitation or runny nose. He does not take any medications. Lungs are clear to auscultation and a chest x-ray shows no acute disease. He reports having tried bronchodilators and Claritin recently with no symptomatic improvement. What is the next step?A. A trial of a proton pump inhibitor B. Pulmonary function tests to r/o COPDC. 24-hour pH monitoringD. Start z-pack for subclinical URIE. Methacholine inhalation test3. An 18-year-old F presents complaining of a very sore throat, swollen lymph nodes in her neck, fever, and general malaise for the past 2 days. She’s febrile at 102.2°F, has enlarged exudative tonsils, tender cervical lymphadenopathy, rapid strep screen is negative. What additional PE findings will you most likely find? A. Increased monocytes on white cell differential B. Enlarged spleenC. IgA antibodies for Epstein-Barr virusD. Decreased atypical lymphocytes on white blood cell differentialAnswers1. D. Pulmonary arteriography2. A. A trial of a proton pump inhibitor3. B. Enlarged spleenWells' Criteria for Pulmonary Embolism: www.mdcalc.com/wells-criteria-pulmonary-embolismPERC Rule for Pulmonary Embolism: www.mdcalc.com/perc-rule-pulmonary-embolismLung sounds: www.youtube.com/watch?v=TlgP8MzlMawFeel free to reach out with questions and suggestions at leonardsee94@gmail.com. IG: @lenny_see

What Every Pharmacist Needs to Know About Sleep: SenioRx Radio Guests: Emily Kryger, PharmD, BCGP Geriatric Clinical Pharmacist & Owner, PharmRecs, LLC Meir Kryger, MD, FRCPC Professor of Medicine (Pulmonary) and Clinical Professor of Nursing, Yale University School of Medicine   Host: Justin Rash, PharmD, BCGP Chair, ASCP Social Media Committee Medical Science Liaison, LTC Description: You won't fall asleep during this podcast! Renowned sleep expert and author of Principles and Practice of Sleep Medicine and The Mystery of Sleep, Dr. Meir Kryger, illuminates sleep disorders in the elderly with his daughter, senior care pharmacist Dr. Emily Kryger.  See omnystudio.com/listener for privacy information.

What Every Pharmacist Needs to Know About Sleep: SenioRx Radio Guests: Emily Kryger, PharmD, BCGP Geriatric Clinical Pharmacist & Owner, PharmRecs, LLC Meir Kryger, MD, FRCPC Professor of Medicine (Pulmonary) and Clinical Professor of Nursing, Yale University School of Medicine   Host: Justin Rash, PharmD, BCGP Chair, ASCP Social Media Committee Medical Science Liaison, LTC Description: You won't fall asleep during this podcast! Renowned sleep expert and author of Principles and Practice of Sleep Medicine and The Mystery of Sleep, Dr. Meir Kryger, illuminates sleep disorders in the elderly with his daughter, senior care pharmacist Dr. Emily Kryger.  See omnystudio.com/listener for privacy information.

This week we Flashback to one of our more popular shows with Christine Oliver, MD. Dr. Oliver joined us to discuss Odors and Chemical Sensitivities about 2 years ago. This was prior to our first YouTube videos so we are going to add some graphics and photos this week. Dr. Oliver is President of Occupational Health Initiatives, Inc. in Brookline, MA. She is an Associate Physician in the Department of Medicine (Pulmonary and Critical Care Division) at the Massachusetts General Hospital (MGH) and Associate Clinical Professor of Medicine at Harvard Medical School in Boston. Board certified in occupational medicine and in internal medicine. Dr. Oliver’s primary specialty is Occupational and Environmental Medicine, with an emphasis on occupational and environmental lung disease. At the MGH she evaluates and cares for patients with occupational and environmental illness and disease, including occupational asthma, interstitial lung disease, building-related health problems, and chemical sensitivities. Dr. Oliver has done research and published in the area of occupational lung disease and she has testified before the United States Congress with regard to work-related health issues and risks. For the past three decades an important focus of Dr. Oliver’s consulting work has been indoor air quality and related health effects. She has lectured and published on this subject and she has been actively involved in indoor air quality assessments in a variety of settings. These include health care facilities, courthouses and other government buildings, schools, and commercial office buildings. Together with industrial hygienists, engineers, and human systems specialists she has worked to identify, characterize, and resolve air quality problems and their related health effects. In 2009 she was a participant and presenter in the ASTM Johnson Conference on the standardization of mold response procedures. An important component of Dr. Oliver’s clinical work has been in the area of fragrances and their related health effects, including causation and/or exacerbation of chemical sensitivities. She has lectured on these topics, counseled patients and their families with regard to steps that can be taken to identify and remove fragranced products from their environment, and advocated for a fragrance-free policy in the clinic in which she works.

This week we Flashback to one of our more popular shows with Christine Oliver, MD. Dr. Oliver joined us to discuss Odors and Chemical Sensitivities about 2 years ago. This was prior to our first YouTube videos so we are going to add some graphics and photos this week. Dr. Oliver is President of Occupational Health Initiatives, Inc. in Brookline, MA. She is an Associate Physician in the Department of Medicine (Pulmonary and Critical Care Division) at the Massachusetts General Hospital (MGH) and Associate Clinical Professor of Medicine at Harvard Medical School in Boston. Board certified in occupational medicine and in internal medicine. Dr. Oliver's primary specialty is Occupational and Environmental Medicine, with an emphasis on occupational and environmental lung disease. At the MGH she evaluates and cares for patients with occupational and environmental illness and disease, including occupational asthma, interstitial lung disease, building-related health problems, and chemical sensitivities. Dr. Oliver has done research and published in the area of occupational lung disease and she has testified before the United States Congress with regard to work-related health issues and risks.    For the past three decades an important focus of Dr. Oliver's consulting work has been indoor air quality and related health effects. She has lectured and published on this subject and she has been actively involved in indoor air quality assessments in a variety of settings. These include health care facilities, courthouses and other government buildings, schools, and commercial office buildings. Together with industrial hygienists, engineers, and human systems specialists she has worked to identify, characterize, and resolve air quality problems and their related health effects. In 2009 she was a participant and presenter in the ASTM Johnson Conference on the standardization of mold response procedures. An important component of Dr. Oliver's clinical work has been in the area of fragrances and their related health effects, including causation and/or exacerbation of chemical sensitivities. She has lectured on these topics, counseled patients and their families with regard to steps that can be taken to identify and remove fragranced products from their environment, and advocated for a fragrance-free policy in the clinic in which she works.

This week on Journal Club we reflect upon the pulmonary artery (PA) catheter. The following articles were discussed: JAMA: The effectiveness of right heart catheterization in the initial care of critically ill patients. SUPPORT Investigators: https://www.ncbi.nlm.nih.gov/pubmed/8782638 BJA: Effect of goal-directed haemodynamic therapy on postoperative complications in low–moderate risk surgical patients: a multicentre randomised controlled trial (FEDORA trial): https://bjanaesthesia.org/article/S0007-0912(17)54207-5/fulltext Perioperative Medicine: Pulmonary artery catheter use in adult patients undergoing cardiac surgery: a retrospective, cohort study: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6201566/ Also, this excellent piece with Thomas Scheeren gets a mention, if you've not heard it yet go here: https://www.topmedtalk.com/talks-to-thomas-scheeren/ Presented by Monty Mythen with Andy Shaw, Chair of the Department of Anesthesiology and Pain Medicine and Zone Clinical Department Head at The University of Alberta, Rupert Pearse, Professor of Intensive Care Medicine at Queen Mary, University of London and Tim Miller, Associate Professor of Anaesthesiology from Duke University Medical Centre.

In this episode, Dr. Perez discusses genetic markers in a population of Iberian gypsies, who are afflicted with a very severe form of pulmonary hypertension that is called pulmonary veno-occlusive disease. Vinicio de Jesus Perez, MD is Assistant Professor of Medicine (Pulmonary and Critical Care Medicine) at the Stanford Adult PH Clinic where he trains fellows pursuing careers in PH and IPF.  Learn more about clinical trials at: www.phaware.global/clinicaltrials. Never miss an episode with the phaware® podcast app. Follow us @phaware on facebook, twitter, instagram, youtube & linkedin Engage for a cure: www.phaware.global/donate #phaware #phawareMD @PHatStanford

In this episode, Dr. Perez discusses health inequality and ways to improve access of care for patients with disadvantageous ethnic backgrounds. Vinicio de Jesus Perez, MD is Assistant Professor of Medicine (Pulmonary and Critical Care Medicine) at the Stanford Adult PH Clinic where he trains fellows pursuing careers in PH and IPF.  Learn more about pulmonary hypertension at www.phaware365.global. Never miss an episode with the phaware® podcast app. Follow us @phaware on facebook, twitter, instagram, youtube & linkedin Engage for a cure: www.phaware.global/donate #phaware #phawareMD @PHatStanford

Vinicio de Jesus Perez, MD is Assistant Professor of Medicine (Pulmonary and Critical Care Medicine) at the Stanford Adult PH Clinic where he trains fellows pursuing careers in PH and IPF. He is principal investigator of a research program with the ultimate goal of identifying new therapeutic targets to treat PH and IPF. In this episode, Dr. Vinicio de Jesus Perez discusses pulmonary arterial hypertension as a complication of methamphetamine use (METH-PAH). Learn more about pulmonary hypertension at www.phaware365.global. Never miss an episode with the phaware® podcast app. Follow us @phaware on facebook, twitter, instagram, youtube & linkedin Engage for a cure: www.phaware.global/donate #phaware #phawareMD @PHatStanford

Vinicio de Jesus Perez, MD is Assistant Professor of Medicine (Pulmonary and Critical Care Medicine) at the Stanford Adult PH Clinic where he trains fellows pursuing careers in PH and IPF. He is principal investigator of a research program with the ultimate goal of identifying new therapeutic targets to treat PH and IPF. In this episode, Dr. Vinicio de Jesus Perez discusses the 4th International Symposium: From Precision Biology to Precision Medicine in Pulmonary Hypertension. Learn more about pulmonary hypertension at www.phaware365.global. Never miss an episode with the phaware® podcast app. Follow us @phaware on facebook, twitter, instagram, youtube & linkedin Engage for a cure: www.phaware.global/donate #phaware #phawareMD

This week we welcome Christine Oliver, MD to the show. Dr. Oliver is President of Occupational Health Initiatives, Inc. in Brookline, MA. She is an Associate Physician in the Department of Medicine (Pulmonary and Critical Care Division) at the Massachusetts General Hospital (MGH) and Associate Clinical Professor of Medicine at Harvard Medical School in Boston. Board certified in occupational medicine and in internal medicine, Dr. Oliver's primary specialty is Occupational and Environmental Medicine, with an emphasis on occupational and environmental lung disease. At the MGH she evaluates and cares for patients with occupational and environmental illness and disease, including occupational asthma, interstitial lung disease, building-related health problems, and chemical sensitivities. Dr. Oliver has done research and published in the area of occupational lung disease and she has testified before the United States Congress with regard to work-related health issues and risks. For the past three decades an important focus of Dr. Oliver's consulting work has been indoor air quality and related health effects. She has lectured and published on this subject and she has been actively involved in indoor air quality assessments in a variety of settings. These include health care facilities, courthouses and other government buildings, schools, and commercial office buildings. Together with industrial hygienists, engineers, and human systems specialists she has worked to identify, characterize, and resolve air quality problems and their related health effects. In 2009 she was a participant and presenter in the ASTM Johnson Conference on the standardization of mold response procedures. An important component of Dr. Oliver's clinical work has been in the area of fragrances and their related health effects, including causation and/or exacerbation of chemical sensitivities. She has lectured on these topics, counseled patients and their families with regard to steps that can be taken to identify and remove fragranced products from their environment, and advocated for a fragrance-free policy in the clinic in which she works

This week we welcome Christine Oliver, MD to the show. Dr. Oliver is President of Occupational Health Initiatives, Inc. in Brookline, MA. She is an Associate Physician in the Department of Medicine (Pulmonary and Critical Care Division) at the Massachusetts General Hospital (MGH) and Associate Clinical Professor of Medicine at Harvard Medical School in Boston. Board certified in occupational medicine and in internal medicine, Dr. Oliver's primary specialty is Occupational and Environmental Medicine, with an emphasis on occupational and environmental lung disease. At the MGH she evaluates and cares for patients with occupational and environmental illness and disease, including occupational asthma, interstitial lung disease, building-related health problems, and chemical sensitivities. Dr. Oliver has done research and published in the area of occupational lung disease and she has testified before the United States Congress with regard to work-related health issues and risks. For the past three decades an important focus of Dr. Oliver's consulting work has been indoor air quality and related health effects. She has lectured and published on this subject and she has been actively involved in indoor air quality assessments in a variety of settings. These include health care facilities, courthouses and other government buildings, schools, and commercial office buildings. Together with industrial hygienists, engineers, and human systems specialists she has worked to identify, characterize, and resolve air quality problems and their related health effects. In 2009 she was a participant and presenter in the ASTM Johnson Conference on the standardization of mold response procedures. An important component of Dr. Oliver's clinical work has been in the area of fragrances and their related health effects, including causation and/or exacerbation of chemical sensitivities. She has lectured on these topics, counseled patients and their families with regard to steps that can be taken to identify and remove fragranced products from their environment, and advocated for a fragrance-free policy in the clinic in which she works